Pharmacologic Contributors to Patent Ductus Arteriosus
动脉导管未闭的药理学贡献者
基本信息
- 批准号:10444540
- 负责人:
- 金额:$ 72.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Adverse effectsAffectAminoglycosidesAnemiaAnimalsAntacidsAntibioticsAortaAreaBiological AssayBirthBlood VesselsChronicChronic lung diseaseComplexCritical IllnessCyclooxygenase InhibitorsDataDatabasesDevelopmentDiseaseDiureticsDrug CombinationsDrug ExposureDrug ScreeningDrug toxicityDrug usageDuctus ArteriosusEvaluationExposure toFailureFurosemideGentamicinsGrantHumanHypoxiaImpairmentIn VitroKidneyKnowledgeLifeLigationLiquid substanceMediatingMolecularMorbidity - disease rateMusMuscle ContractionMyographyNeonatalNeonatal Intensive Care UnitsNewborn AnimalsNewborn InfantOperative Surgical ProceduresPatent Ductus ArteriosusPathway interactionsPharmaceutical PreparationsPharmacological TreatmentPharmacologyPharmacopoeiasPhasePhysiologicalPregnancyPremature InfantPropertyProstaglandin-Endoperoxide SynthaseProstaglandinsPulmonary artery structureRelaxationResearchRiskRisk FactorsSepsisSeriesShunt DeviceSignal TransductionSmooth MuscleSmooth Muscle MyocytesStimulusTestingTherapeuticTimeToxic effectTransfusionUterusVasoconstrictor AgentsVasodilator AgentsWomanbaseclinically relevantconstrictioncytotoxicitydrug candidatefetalfetal bloodgene networkhigh risk infanthigh throughput screeninghuman datahuman tissuein vivoinnovationinterestmodifiable riskmortalitymouse modelneonatal humanneonatal miceneonatenovelpostnatalprematureprenatal exposurepressurepreterm newbornpreventscreeningsealskillstranslational potential
项目摘要
Project Summary
Vascular adaptation after birth is dependent on closure of the ductus arteriosus (DA), a fetal vascular shunt
connecting the pulmonary artery and aorta. Failure of DA closure results in persistent patency of the DA (PDA),
a common disorder associated with increased morbidity and mortality in the most vulnerable infants. Current
pharmacological treatments for PDA are limited and only focus on a single therapeutic pathway –
cyclooxygenase-mediated prostaglandin (PG) synthesis. However, recent data reveal complex networks of
genes and druggable pathways involved in the vasodilatory-to-vasoconstrictive shift that drives postnatal DA
closure. Efforts to identify new DA-selective vasoconstrictors overlook the possibility that ongoing vasodilatory
stimuli perpetuate DA relaxation and inhibit its closure. Because critically ill preterm newborns are exposed to
multiple medications during the time that DA closure takes place, we postulate that pharmacologic agents used
in the neonatal ICU prevent DA closure and contribute to PDA.
The DA of prematurely-born infants is developmentally primed to respond to vasodilatory signals. Our prior
studies using mouse models and human data show that drugs frequently used in preterm infants have
unexpected vasodilatory effects on the DA, including specific antibiotics, antacids, and diuretics. These data
suggest that drug-induced DA relaxation is a modifiable contributor to PDA, but this has not been systematically
evaluated. We therefore hypothesize that drugs commonly used in the NICU have an adverse effect on
closure of the premature DA and that specific drug combinations act synergistically to impair postnatal
DA closure. Mouse and human tissues will be used to test this hypothesis in three Aims: 1) Determine whether
drugs in the neonatal pharmacopeia prevent the initial phase of DA closure - smooth muscle constriction - that
leads to physiologic closure of the DA lumen; 2) Determine whether drugs in the neonatal pharmacopeia impair
the second phase of DA closure - fibromuscular remodeling - that leads to permanent sealing of the constricted
DA; 3) Identify drug combinations that interact to adversely affect either phase of DA closure. Drug effects will
be examined using primary (in vitro) high throughput screening (HTS) of preterm mouse DA smooth muscle
cells. A series of secondary screening assays will prioritize single- and synergistic combinations of hits based
on potency/efficacy, DA-selectivity, and toxicity for further study of their ex vivo and in vivo vasoactive effects on
the DA. A novel ex vivo mouse DA-reopening assay will be used to screen for drugs of interest. The effect of hit
DA-vasodilatory compounds will be examined on ex vivo human neonatal DA segments and in a large national
database of preterm infants. These studies have high translational potential and will definitively identify which
drugs or drug combinations pose increased risks for PDA in preterm infants, providing an innovative approach
to enhance conservative PDA management efforts in the NICU.
项目摘要
出生后的血管适应依赖于动脉导管(DA)的关闭,DA是一种胎儿血管分流
连接着肺动脉和大动脉。DA关闭失败导致DA(PDA)持续通畅,
这是一种常见的疾病,与最脆弱婴儿的发病率和死亡率增加有关。当前
PDA的药物治疗是有限的,只集中在单一的治疗途径上-
环氧合酶介导的前列腺素(PG)合成。然而,最近的数据揭示了复杂的
参与驱动出生后DA的血管舒缩转变的基因和可用药途径
结案了。寻找新的DA选择性血管收缩药的努力忽略了正在进行的血管扩张
刺激使DA松弛永久化,并抑制其关闭。因为危重的早产儿暴露在
在DA关闭的过程中,我们假设使用了多种药物
在新生儿ICU中,防止DA关闭,有助于PDA的发生。
早产儿的多巴胺在发育过程中准备好对血管扩张信号做出反应。我们的前辈
使用老鼠模型和人类数据的研究表明,经常用于早产儿的药物有
对DA产生意想不到的血管扩张作用,包括特定的抗生素、抗酸剂和利尿剂。这些数据
提示药物诱导的DA松弛是PDA的一个可改变的因素,但这还没有得到系统的研究
已评估。因此,我们假设NICU中常用的药物对
早产DA的关闭和特定的药物组合协同作用损害出生后
DA结案了。老鼠和人体组织将被用来检验这一假说的三个目的:1)确定
新生儿药典中的药物预防DA闭合的初始阶段--平滑肌收缩--
导致DA管腔的生理性闭合;2)确定新生儿药典中的药物是否损害
DA闭合的第二阶段--纤维肌肉重塑--导致狭窄处的永久性闭合
DA;3)确定相互作用对DA关闭的任一阶段产生不利影响的药物组合。药物效应将会
用原代(体外)高通量筛选(HTS)方法检测早产小鼠DA平滑肌
细胞。一系列二次筛查分析将优先考虑基于单一和协同组合的HITS
为进一步研究它们的体内外血管活性作用,对其效力/效力、DA选择性和毒性进行了研究
地方检察官。一种新的体外小鼠DA重启试验将用于筛选感兴趣的药物。HIT的效果
大血管扩张化合物将在体外的人类新生儿DA节段和大型国家
早产儿数据库。这些研究具有很高的翻译潜力,并将最终确定哪些
药物或药物组合增加了早产儿PDA的风险,提供了一种创新的方法
加强NICU保守的掌上电脑管理工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Jeffrey Reese其他文献
John Jeffrey Reese的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Jeffrey Reese', 18)}}的其他基金
Pharmacologic Contributors to Patent Ductus Arteriosus
动脉导管未闭的药理学贡献者
- 批准号:
10653150 - 财政年份:2022
- 资助金额:
$ 72.01万 - 项目类别:
Preventing Prematurity and Poor Pregnancy Outcomes Training Grant
预防早产和不良妊娠结局培训补助金
- 批准号:
8658837 - 财政年份:2011
- 资助金额:
$ 72.01万 - 项目类别:
Preventing Prematurity and Poor Pregnancy Outcomes Training Grant
预防早产和不良妊娠结局培训补助金
- 批准号:
8470673 - 财政年份:2011
- 资助金额:
$ 72.01万 - 项目类别:
Role of natriuretic peptides in the ductus arteriosus
利尿钠肽在动脉导管中的作用
- 批准号:
8235789 - 财政年份:2010
- 资助金额:
$ 72.01万 - 项目类别:
Role of natriuretic peptides in the ductus arteriosus
利尿钠肽在动脉导管中的作用
- 批准号:
8060572 - 财政年份:2010
- 资助金额:
$ 72.01万 - 项目类别:
Role of natriuretic peptides in the ductus arteriosus
利尿钠肽在动脉导管中的作用
- 批准号:
8442344 - 财政年份:2010
- 资助金额:
$ 72.01万 - 项目类别:
Role of natriuretic peptides in the ductus arteriosus
利尿钠肽在动脉导管中的作用
- 批准号:
7887939 - 财政年份:2010
- 资助金额:
$ 72.01万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 72.01万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 72.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 72.01万 - 项目类别:
Studentship